Giuseppina Apicella1, Marina Paolini1, Letizia Deantonio2, Laura Masini1, Marco Krengli3. 1. Radiotherapy Division, University Hospital "Maggiore della Carità", Novara, Italy. 2. Radiotherapy Division, University Hospital "Maggiore della Carità", Novara, Italy; Department of Translational Medicine, University of "Piemonte Orientale", Novara, Italy. 3. Radiotherapy Division, University Hospital "Maggiore della Carità", Novara, Italy; Department of Translational Medicine, University of "Piemonte Orientale", Novara, Italy; Centro Nazionale Adroterapia Oncologica (CNAO), Pavia, Italy.
Abstract
BACKGROUND: The management of vestibular schwannoma is still a quite controversial issue and can include wait and see policy, surgery and radiotherapy, mainly with stereotactic technique. The purpose of this study is to review the results of recent clinical series treated by radiotherapy. MATERIALS AND METHODS: Literature search was performed by Pubmed and Scopus by using the words "vestibular schwannoma, acoustic neuroma, radiotherapy, radiosurgery". RESULTS: Management options of VS include wait and see, surgery and radiotherapy. In case of small lesions, literature data report local control rates higher than 90% after radiosurgery (SRS) similar those of surgical techniques. Recent literature reviews show favourable functional outcome by using SRS. Several literature data support the use of fractionated stereotactic radiotherapy (FSRT) in case of large inoperable lesions. CONCLUSION: Radiotherapy plays a relevant role in the treatment of VS. In small-size lesions, SRS can guarantee similar local control and potentially better function outcome compared to surgery. In case of large and irregularly shaped lesions, FSRT can be the used when surgery is not feasible.
BACKGROUND: The management of vestibular schwannoma is still a quite controversial issue and can include wait and see policy, surgery and radiotherapy, mainly with stereotactic technique. The purpose of this study is to review the results of recent clinical series treated by radiotherapy. MATERIALS AND METHODS: Literature search was performed by Pubmed and Scopus by using the words "vestibular schwannoma, acoustic neuroma, radiotherapy, radiosurgery". RESULTS: Management options of VS include wait and see, surgery and radiotherapy. In case of small lesions, literature data report local control rates higher than 90% after radiosurgery (SRS) similar those of surgical techniques. Recent literature reviews show favourable functional outcome by using SRS. Several literature data support the use of fractionated stereotactic radiotherapy (FSRT) in case of large inoperable lesions. CONCLUSION: Radiotherapy plays a relevant role in the treatment of VS. In small-size lesions, SRS can guarantee similar local control and potentially better function outcome compared to surgery. In case of large and irregularly shaped lesions, FSRT can be the used when surgery is not feasible.
Authors: Carys Thomas; Salvatore Di Maio; Roy Ma; Emily Vollans; Christina Chu; Brenda Clark; Richard Lee; Michael McKenzie; Montgomery Martin; Brian Toyota Journal: J Neurosurg Date: 2007-11 Impact factor: 5.115
Authors: R L Foote; R J Coffey; J W Swanson; S G Harner; C W Beatty; R W Kline; L N Stevens; T C Hu Journal: Int J Radiat Oncol Biol Phys Date: 1995-07-15 Impact factor: 7.038
Authors: Khodayar Goshtasbi; Mehdi Abouzari; Omid Moshtaghi; Marlon Maducdoc; Brandon M Lehrich; Harrison W Lin; Hamid R Djalilian Journal: Otolaryngol Head Neck Surg Date: 2019-03-19 Impact factor: 3.497
Authors: Khodayar Goshtasbi; Mehdi Abouzari; Omid Moshtaghi; Ronald Sahyouni; Autefeh Sajjadi; Harrison W Lin; Hamid R Djalilian Journal: Laryngoscope Date: 2019-04-05 Impact factor: 3.325
Authors: Scott G Soltys; Michael T Milano; Jinyu Xue; Wolfgang A Tomé; Ellen Yorke; Jason Sheehan; George X Ding; John P Kirkpatrick; Lijun Ma; Arjun Sahgal; Timothy Solberg; John Adler; Jimm Grimm; Issam El Naqa Journal: Int J Radiat Oncol Biol Phys Date: 2020-12-26 Impact factor: 8.013
Authors: Mira A Patel; Ariel E Marciscano; Chen Hu; Ignacio Jusué-Torres; Rupen Garg; Arif Rashid; Howard W Francis; Michael Lim; Kristin J Redmond; Daniele Rigamonti; Lawrence R Kleinberg Journal: Front Oncol Date: 2017-09-04 Impact factor: 6.244
Authors: Umberto Tosi; Sergio Guadix; Anjile An; Drew Wright; Paul J Christos; Susan Pannullo; Andrew Brandmaier; Jonathan P S Knisely; Philip E Stieg; Rohan Ramakrishna Journal: Neurooncol Pract Date: 2021-02-01